Drug profile · INN
mepivacaine hydrochloride
ISOCAINE HYDROCHLORIDE
mepivacaine hydrochloride (ISOCAINE HYDROCHLORIDE) is a sodium channel alpha subunit blocker. Route of administration: injection. Current US regulatory status: approved.
Drug details — mepivacaine hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
mepivacaine hydrochloride (ISOCAINE HYDROCHLORIDE) is a sodium channel alpha subunit blocker. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Sodium channel alpha subunit blocker
Primary target: Sodium channel alpha subunit
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is mepivacaine hydrochloride?
mepivacaine hydrochloride (ISOCAINE HYDROCHLORIDE) is a sodium channel alpha subunit blocker. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for mepivacaine hydrochloride?
ISOCAINE HYDROCHLORIDE is a marketed brand name for mepivacaine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of mepivacaine hydrochloride?
mepivacaine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.